MedTrace Logo

Effect of Lost Wage Reimbursement to Kidney Donors on Living Donation Rates

NCT03350269 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1310

Last updated 2022-01-03

No results posted yet for this study

Summary

The study is designed as a randomized controlled trial. The investigators hypothesize that kidney transplant recipient candidates whose donors are offered reimbursement of lost wages (treatment arm) will have a higher probability of receiving a living donor kidney transplant than those randomized to no offer of lost wage reimbursement (control arm). The study expects to demonstrate incremental living donor kidney transplants by assisting individuals who wish to be living organ donors but would be otherwise unable to do so due to the obligatory forfeit of income during the evaluation, donation surgery, and post-operative recuperation periods.

Conditions

Interventions

OTHER

Information provision

Kidney transplant recipients are informed that their donors may be eligible for lost wage reimbursement

Sponsors & Collaborators

  • Laura and John Arnold Foundation

    collaborator OTHER

  • American Society of Transplant Surgeons

    collaborator OTHER

  • Arbor Research Collaborative for Health

    lead OTHER

Principal Investigators

  • Kimberly A. Gifford, MBA · American Society of Transplant Surgeons

  • Judd Kessler, PhD · Wharton School, University of Pennsylvania

  • Robert M. Merion, MD, FACS · Arbor Research Collaborative for Health

  • Amit K. Mathur, MD · Mayo Clinic

  • Akinlolu O. Ojo, MD, PhD, MBA · University of Arizona Health Sciences

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-15
Primary Completion
2020-06-17
Completion
2020-10-20

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03350269 on ClinicalTrials.gov